BiomX CEO to Showcase Innovations at Investment Conference
![BiomX CEO to Showcase Innovations at Investment Conference](https://investorshangout.com/images/blog/ihnews-BiomX%20CEO%20to%20Showcase%20Innovations%20at%20Investment%20Conference.jpg)
BiomX to Present at the H.C. Wainwright Investment Conference
BiomX Inc. (NYSE American: PHGE), a clinical-stage company pioneering natural and engineered phage therapies, is thrilled to announce its upcoming presentation at the H.C. Wainwright 26th Annual Global Investment Conference. Jonathan Solomon, the Chief Executive Officer of BiomX, will lead the session, sharing insights on the company's innovative approach to treating chronic diseases through phage technology.
Event Details
The conference will take place at the Lotte New York Palace Hotel from September 9 - 11. Jonathan Solomon's presentation is scheduled for September 9, and attendees can access it on-demand starting at 7:00 AM ET.
Replay Availability
A recording of the presentation will be hosted on BiomX’s website under the Events & Presentations section, providing access for those unable to join live. The replay will be available for 90 days, ensuring broader accessibility.
Meetings and Networking Opportunities
During the conference, Mr. Solomon will also be available for one-on-one meetings, offering a fantastic opportunity for investors and stakeholders to engage directly with the company's leadership. Interested parties are encouraged to request meetings and learn more about the exciting developments at BiomX.
About BiomX
BiomX is at the forefront of developing groundbreaking phage therapies aimed at significantly impacting the treatment of chronic diseases. By harnessing the power of naturally occurring bacteriophages, the company customizes treatments to target and destroy harmful bacteria, addressing substantial unmet medical needs. Utilizing its proprietary BOLT platform, BiomX identifies and validates bacterial targets, allowing for the customization of phage cocktails uniquely suited for patients' needs.
Innovative Therapeutic Approaches
As a clinical-stage entity, BiomX actively advances its pipeline of phage therapies, each designed to tackle specific pathogenic bacteria linked to chronic conditions. The potential benefits of these therapies extend beyond traditional antibiotic treatments, aiming for a more efficient and targeted approach to managing bacterial infections.
Contact Information
If you would like to learn more about BiomX and its innovative strategies in phage therapy, please feel free to reach out:
BiomX, Inc.
Assaf Oron
+972-54-2228901
assafo@biomx.com
Investors:
CORE IR
Peter Seltzberg
peters@coreir.com
Frequently Asked Questions
What is BiomX focusing on at the investment conference?
BiomX will present an overview of its innovative phage therapies aimed at treating chronic diseases.
When can attendees access the presentation?
The on-demand presentation will be available starting at 7:00 AM ET on September 9.
How can I request a meeting with the CEO?
Interested individuals can request one-on-one meetings with Jonathan Solomon during the conference through a registration process.
What is the BOLT platform?
BOLT stands for BacteriOphage Lead to Treatment and is BiomX's proprietary platform for customizing phage therapies.
What makes phage therapy different from traditional antibiotics?
Phage therapy targets specific bacteria, offering a potential alternative to antibiotics that often affect beneficial flora and contribute to antibiotic resistance.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- Cetera Welcomes Experienced Advisors to Wealth Partners Team
- GlobalVetLink's Automation Tool Enhances Rabies Vaccine Management
- Randstad US Study: Political Conversations and Workplace Safety
- CIBC Mellon, UPP & IMCO to Host Investment Fund Conference
- Hackensack Meridian Health Foundation Gala Honors Eli Manning
- UK Investor Behavior: Shift from Stocks to Money Markets
- Apple's Anticipated 'Glowtime' Event to Unveil Innovations
- Rising Bankruptcy Filings in Commercial Sector Highlight Trends
- Metabolomics Technologies Market Set to Surge by 2034
- Brunswick Corporation Awarded Trustworthy Company Recognition
- Prepare for Safety: Michigan Church Security Conference 2024
- Myosin's Innovative Marketing Platform Redefines Advertising Impact
- Goya Foods Launches GOYA® Cares Hydrate for Hope Campaign
- Acer Introduces Eco-Friendly Vero PD2 Series LED Projectors
- Tower Arch Capital Partners with ACS Manufacturing for Growth
- Winking Studios Unveils GenMotion.AI for 3D Animation Innovation
- Norfolk Southern Signs Tentative Agreements with SMART-TD Unions
- Wells Fargo Advises Investors to Buy Election Weakness
- Tech Stocks Struggle Amid Economic Growth Concerns
- Blue Circle Health Launches New T1D Program in Northern States
- West Shore Home Appoints Al Patel as New Chief Marketing Officer
- Digestion Resistant Maltodextrin Market Set for Remarkable Growth
- Mid-Atlantic BioTherapeutics and Accelero Unite for Drug Discovery
- Peptide Therapeutics Market to Reach USD 85.9 Billion by 2031
- Saphyre and WTax Launch Innovative Tax Reclaim Solutions
Recent Articles
- Cetera Welcomes Experienced Advisors to Wealth Partners Team
- Essential Gutter Maintenance Tips for Autumn Care This Season
- African Leaders Forge Pragmatic Ties with Chinese Localities
- Cleveland Schools Optimize Savings with EcoChem's Clean Fuel
- Dental Charting Software Market Expected to Surge by 2034
- China and Africa: Progressing Towards Common Prosperity
- Class Action Settlement for Packaged Tuna Purchasers Explained
- Cineverse Expands Data Security with LiveRamp Integration
- Cloud Monitoring Market Set for Remarkable Growth Ahead
- Sonnet BioTherapeutics to Join Virtual Investor Event Soon
- Saudi Arabia's Stock Market Overview: Tadawul Performance Insights
- Aurigo Software Enhances Right of Way Solutions for Agencies
- FangDD Provides Important Updates on Substitution Listing
- Midi Health and Mount Sinai Team Up for Menopause Care Access
- RECOVER 180™ Prepares for NFL 2024-25 Season with Athletes
- Nordstrom Founders Propose $23 Per Share Takeover Bid
- Net-Trade.com Celebrated as a Key Influencer in Net Lease
- Praxis Precision Medicines Showcases Epilepsy Innovations
- Alchemi Data Management Partners with Phoenix Data Corporation
- US Futures Decline Amid Economic Growth Concerns
- GoHealth Expands by Acquiring e-TeleQuote in Medicare Market
- Invivyd Begins Phase 1 Trial for VYD2311 to Combat COVID-19
- Enstar Concludes Go-Shop Phase Amid $5.1 Billion Acquisition
- Alamos Gold Unveils Exciting Developments at PDA Project
- Protalix BioTherapeutics Set to Present at Key Investment Conference